In vitro studies showed improved IgA-mediated ADCC by PMNs upon disruption of the CD47-SIRPα interaction in SKBR3 and A431 cells, either by blocking SIRPα or knocking out CD47 in the tumor cell line. This evidence concerns the gene CD79A and neoplasm.